



Inherited hemoglobinopathies are a large group of disorders that 
include thalassemia syndromes and structural hemoglobin (Hb) 
variants. Alpha thalassemia (α thalassemia) is caused by a decreased 
or abnormal synthesis of α globin chains. The genetic background 
includes deletions of one (α+-thalassemia) or both α-globin genes 
(α0-thalassemia) from the chromosome 16p13.3. Molecular analysis 
has shown that healthy individuals have genotype αα/αα (4 functional 
genes). The deletions which remove a single gene result in the 
silent carrier state (α-/αα), and others which remove two, three or 
four genes – lead to α-thalassmia trait (--/αα), HBH (hemoglobin H) 
disease (--/-α) or to Hb Barts hydrops fetalis syndrome respectively. 
The nondeletional mutations (point mutations or oligonucleotide 
insertions/deletions) have been recognized occasionally. Some of 
them may lead to more severe reduction in α-chain synthesis than the 
deletion α+ -thalassemia [1] whereas others lead to abnormal α chain 
hemoglobins (α globin chain variants) which are non pathological 
[2, 3]. In this report we present the compound heterozygosity for 
nondeletional (Hb Handsworth) and deletional (-α3.7) α-thalassemia 
mutations in an adult Polish woman. The 3.7 single-gene deletion 
(rightward deletion) is the most common alpha-thalassemia mutation 
worldwide [4] and in Poland [5, 6]. It is caused by reciprocal (inverse) 
recombination between Z segments (in α –globin gene cluster) during 
meiosis whereas the, Hb Handsworth (HBA2 or HBA1: c.55G > C, 
p.Gly19Arg) is rare and has never been detected in the Polish 
population. The first case of Hb Handsworth was determined in a 12 
year old boy of West Indian origin [7]. It was also detected in a British 
patient [8], an Iran patient [3] and an inhabitant of the Netherlands [9]. 
In HPLC (high-performance liquid chromatography) analysis as well 
as in other routine laboratory methods the hemoglobin coded by DNA 
with this mutation, can be mistaken with HbS since both elute in the 
“S” window compartment [10].
The aim of this communication is to highlight the occurrence of 
compound hetreozygotes in α-globin gene defects in Northern 
Europe.
Materials and methods
A 32-year-old Polish woman was diagnosed for red blood cell 
microcytosis with no iron deficiency in the outpatient clinic of Institute 
of Hematology and Transfusion Medicine in Warsaw. Complete blood 
counts on Cell Dyn 4000 automated analyzer was performed within 
24 hours of sample collection.
Biochemical analysis included microcolumn chromatography for 
quantization of HbA2 (Beta-Thal HbA2 Quick Column (Helena 
Biosciences)) and alkaline denaturation procedure for measurement 
of HbF and alkaline and acid hemoglobin electrophoresis (Sebia) to 
detect pathological hemoglobin fraction.
Genomic DNA was extracted from peripheral blood with EDTA 
leucocytes by using a blood genomic extraction kit Nucleospin Dx 
Blood (Machery Nagel) and kept at +4ºC. DNA concentration was 
determined by NANODROP spectrophotometer. The α-globin gene 
mutations were identified using the gap-polymerase reaction (gap- 
PCR) technique for the seven common deletions: single gene 
deletions (-α3.7 -α4.2 ) and both gene deletions: --FIL, --SEA, --MED I, --20.5, 
--THAI as described by Kidd et al. [11] and α gene triplications using the 
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PCR [12]. Results were visualized by separating PCR products using 
ethidium bromide-stained 2% agarose gel electrophoresis.
Multiplex ligation-dependent probe amplification (MLPA) assay in 
α-globin gene cluster was performed using the Salsa MLPA P140-C1 
HBA kit (MRC-Holland, Amsterdam, The Netherlands) according to 
the manufacturer’s instructions.
DNA sequencing of HBA2, HBA1 [13] and HBB was performed using 
specific F and R primer set and the ABI Prism Big Dye Terminator 
v1.1 Cycle Sequencing kit on an ABI PRISM 3730 Genetic Analyser 
(Applied Biosystems, USA) according to the instructions of the 
manufacturer.
Results
Hematological analysis revealed: Hb 12,5 g/dl, MCV 72,6 fl and 
MCH 24,8 pg. Plasma ferritin concentration, serum bilirubin level 
and reticulocyte count were within normal. The levels of HbA2 and 
HbF were 2,2% and 1,0% respectively. The detail hematological and 
biochemical profile is summarized in table I.
Hemoglobin electrophoresis on agarose gel alkaline pH showed 
a strong band migrating in a position of hemoglobin S and faint bands 
in the neighborhood of band A on acid electrophoresis were observed 
(Fig. 1).
Direct sequencing of the β-globin gene showed no mutations 
that might lead to pathological changes in the protein and direct 
sequencing of HBA2, HBA1 genes revealed the presence of GGC 
(Gly) to CGC (Arg) substitution at codon 19 in HBA2 (Fig. 2). Further 
alpha globin gene study (gap-PCR and MLPA) revealed this woman 
to be a carrier of the deletion -α3.7 (Fig. 3). The presence of α gene 
triplications was excluded.
Discussion
In this paper we report a case of simultaneous detection of Hb 
Handsworth and a -α3.7-thalassemia deletion mutation in an adult 
woman of Caucasisn origin. To the best of our knowledge this 
is the first report of such case in Poland. Thalassemia alpha, as 
well as thalassemia beta belong to a group of genetic disorders of 
hemoglobin synthesis both of which are rare in Northern Europe. 
Until quite recently these diseases were considered non-existent 
healthcare problems in Poland.
For many years the diagnosis of β-thalassemia both in our Institute 
laboratory and in other countries, was mainly based on the level 
of HbA2 [14, 15, 16] and α-thalassemia remained undiagnosed. 
Following the implememntation of molecular techniques (gap- 
PCR, MLPA, sequencing of genes) we recognized several cases of 
α-thalassemia with various molecular backgrounds [5, 6].
The woman described in this paper has microcytosis and hipochromia 
with no evidence of iron deficiency. She had been given oral iron 
suplementation several times. Family history of hereditary anemia is 
unavailable.
Biochemical analysis for quantization of HbA2 and HbF was normal 
but band migration with HbS position on alkaline electrophoresis and 
additional band on acid electrophoresis suggest that the patient has 
hemoglobinopathy. It is noteworthy that the presence of band migration 
at the HbS position on alkaline agarose gel can lead to misdiagnosis 
in the diagnostic schedules for thalassemia/hemoglobinopathy. We 
performed the sequencing of HBB gene and no mutations in this gene 
were detected. We also performed sequencing of HBA2 and HBA1 
genes which revealed homozygous point mutation that results in the 
appearance of Hb Handsworth in HBA2 gene. We then found that the 
Table I. Hematological and biochemical data and patient’s gen- 
otype
Parameters Patient












Fig. 1. Agarose gel electrophoresis at alkaline (A – lane 5) and 
acid pH (B – lane 6) showing bands in the A and S position (A –
lane 5) and bands in A position and bands in the neighborhood 





A – lane 5 
1       2      3      4      5     6       7  
B – lane 6 
    1     2     3     4     5     6     7  
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patient carried a single gene -α3.7 deletion. One must note that the 
primers specific for normal α-2 globin gene cannot amplify the fusion 
α gene on the chromosome with the -α3.7 deletion. We must conclude 
that mutation: HBA2: c.55G>C is in trans to the -α3.7 deletion. 
Hb Handsworth like some α variants seems to be clinically 
asymptomatic (normal MCV and MCH) [3, 17, 18], but our case 
carries -α3.7 deletion allele as well. Our double heterozygote however 
presented only mild anemia, which is typical for silent α- thalassemia 
phenotype.
It is noteworthy that Hb Handsworth diagnosis may be problematic 
as this hemoglobin “co-migrates” with HbS on agarose alkaline 
electrophoresis and creates very mild bands in acid electrophoresis. 
Routine use of molecular biology techniques such as gap-PCR, gene 
sequencing, and MLPA allowed for better defining of thalassemic 
genotypes (compound heterozygosity for abnormal hemoglobin and 
thalassemia mutations) and for correction of differential diagnosis of 
microcytic anemia.
We presented the molecular analysis of thalassemias taking into 
account the process of spreading multi-ethnicity in Northern Europe 
which results in growing consciousness of the problem assiociated 
with the common hemoglobinopathies such as HbS [19]. We 
must emphasize however that our particular case was detected 
in a Caucasian woman, which may suggest that alfa thalassemia 
and hemoglobinopathies are also present in the Polish population 
but were undetected prior to implementation of molecular biology 
methods. Confirmation of thalassemia diagnosis is important because 
Fig. 2. DNA sequence analysis of the patient showing a GGC > CGC mutation at codon 19 of the α2-globin gene which results in the 
amino acid substitution (p.Gly19Arg).The arrow indicates the place of mutation
Fig 3. MLPA analysis of the patient’s α-globin gene cluster allowed to detect the heterozygous deletion -α3.7
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similar findings in blood morphology (microcytosis) are typical for iron 
deficiency; patients are therefore often exposed to unnecessary iron 
supplementation.
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